Target intelligence / Profile preview

Odontogenic ameloblast-associated protein (ODAM)

Target
ODAM
Molecular classification
Other
01

Overview

Odontogenic ameloblast-associated protein (ODAM) is a secreted protein predominantly expressed during tooth development by maturation stage ameloblasts and in the junctional epithelium (JE), where it accumulates at the interface between the basal lamina and enamel[1][2]. ODAM plays a fundamental role in mediating adhesion between epithelial cells and the tooth surface, regulating JE regeneration and epithelial integrity, and participating in cell signaling events related to cytoskeletal reorganization via the integrin-ODAM-ARHGEF5-RhoA pathway. Loss of ODAM expression is associated with pathological states such as periodontal disease and peri-implantitis, while its detection in gingival fluids serves as a biomarker for tissue damage and disease progression. Research has also shown anti-cancer properties of ODAM and its utility as a prognostic marker in malignant transformation, although its precise mechanism in neoplastic tissues remains under investigation[1][2]. Currently, no therapeutic drugs directly target ODAM, but its potential as a target for regeneration therapies is being explored.

Other names
Odontogenic, ameloblast-associatedODAMAPINApinFLJ20513odontogenic ameloblast-associated proteinodontogenic, ameloblast associatedodontogenic, ameloblast asssociated
02

Biological functions

Cell adhesionSignal transductionEpithelial regenerationExtracellular signaling (e.g., WNT, ARHGEF5-RhoA, BMP-2-BMPR-IB-ODAM pathways)
03

Disease associations

CancerInflammationPeriodontal diseases (e.g., periodontitis, peri-implantitis)Tissue regeneration
04

Biomarkers

Periodontitis (presence of ODAM in gingival crevicular fluid reflects loss of junctional epithelium attachment)Peri-implantitisEpithelial regeneration statusPrognostic biomarker in some cancers

Beyond the preview

Go deeper on Odontogenic ameloblast-associated protein (ODAM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Odontogenic ameloblast-associated protein (ODAM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call